Nautilus Biotechnology, Inc.
NAUT
$2.51
$0.041.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -17.01% | -13.84% | -11.58% | -2.52% | 7.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.97% | -12.40% | -7.92% | -1.24% | 6.99% |
| Operating Income | 17.97% | 12.40% | 7.92% | 1.24% | -6.99% |
| Income Before Tax | 16.64% | 10.53% | 5.68% | -1.81% | -11.16% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 16.64% | 10.53% | 5.68% | -1.81% | -11.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.64% | 10.53% | 5.68% | -1.81% | -11.16% |
| EBIT | 17.97% | 12.40% | 7.92% | 1.24% | -6.99% |
| EBITDA | 18.05% | 12.43% | 8.00% | 1.30% | -6.88% |
| EPS Basic | 17.03% | 11.15% | 6.27% | -1.20% | -10.60% |
| Normalized Basic EPS | 17.54% | 13.53% | 8.86% | 1.74% | -7.07% |
| EPS Diluted | 17.03% | 11.15% | 6.27% | -1.20% | -10.60% |
| Normalized Diluted EPS | 17.54% | 13.53% | 8.86% | 1.74% | -7.07% |
| Average Basic Shares Outstanding | 0.45% | 0.71% | 0.64% | 0.61% | 0.52% |
| Average Diluted Shares Outstanding | 0.45% | 0.71% | 0.64% | 0.61% | 0.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |